Influence of COVID‑19 on the Prognosis and Medication Compliance of Glaucoma Patients in the Nile Delta Region

Mohamed A Awwad, Mohamed Masoud Department of Ophthalmology, Benha University Hospital, Benha, Qualubia, EgyptCorrespondence: Mohamed A AwwadDepartment of Ophthalmology, Benha University Hospital, Benha, Qualubia, EgyptTel +201017014208Email mohamed.awad@fmed.bu.edu.eg; mohdzahir82.ma@gmail.comObjec...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Awwad MA, Masoud M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/4088b8bf6c8a47719f214454990f6d9e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Mohamed A Awwad, Mohamed Masoud Department of Ophthalmology, Benha University Hospital, Benha, Qualubia, EgyptCorrespondence: Mohamed A AwwadDepartment of Ophthalmology, Benha University Hospital, Benha, Qualubia, EgyptTel +201017014208Email mohamed.awad@fmed.bu.edu.eg; mohdzahir82.ma@gmail.comObjective: To assess the influence of the COVID-19 pandemic on the medication adherence and follow-up of glaucoma patients in the Nile Delta region.Setting: A tertiary care center in the Nile Delta region, Egypt.Study Design: An observational, cross-sectional study.Participants: Patients’ records (2019– 2020; group A) and (2020– 2021; group B) were assessed for missed follow-up visits, medication adherence, number of trabeculectomies performed, and uncontrolled patients. In addition, a telephone-based questionnaire involving randomly chosen 200 patients from B.G.U. was carried out to clarify the potential causes of poor patients’ compliance.Results: There was a marked decline in the number of newly diagnosed patients and patients on regular follow-up with incidence rates 0.208 and 0.088 in group (A) and group (B), respectively (P-value < 0.0001). The number of compliant patients in group B decreased with an incidence rate difference of 0.312. The number of trabeculectomies declined in group (B) with an incidence rate in group (A) 0.131 compared to 0.081 in group (B). On the other hand, the number of uncontrolled glaucoma patients increased in group B with an incidence rate difference − 0.231 between the two groups. 21.5% of patients who participated in the questionnaire identified financial issues as the leading cause of non-compliance. Comorbidities (19.5%), lockdown and transportation difficulties were also highlighted.Conclusion: COVID-19 had greatly hampered glaucoma care in the Nile Delta region. As a result, we need to implement new technologies like telemedicine and improve patients’ awareness of glaucoma care. Training orthoptists and using mobile glaucoma care services would also be helpful ways of managing glaucoma during that pandemic.Keywords: COVID-19, glaucoma, compliance, follow-up, questionnaire